Hong Kong Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)

Tong Ren Tang Technologies

Market Cap: HK$6.1b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Consun Pharmaceutical Group

Market Cap: HK$13.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.9b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

SSY Group

Market Cap: HK$8.5b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Shanghai Haohai Biological Technology

Market Cap: HK$11.6b

Shanghai Haohai Biological Technology Co., Ltd.

China Shineway Pharmaceutical Group

Market Cap: HK$6.2b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Jacobson Pharma

Market Cap: HK$2.9b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.